Assertio Therapeutics Inc (ASRT) support and resistance · rev $125.0M
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
This page maps Assertio Therapeutics Inc (ASRT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
ASRT currently screens at market cap $151.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ASRT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ASRT quote page for the session range and the stock page for the full model.
Not investment advice.